Product & regulatory approvals

Gates that opened: regulatory and product approvals — drug approvals, licences, clearances — disclosed to the exchanges inside the window. The approval filing is linked on every row.

CompanyWhy it’s here — the filingReaction 1d / 1w / 1mPriceMcapP/EROCERev YoY
GEEOther Electrical EquipmentGEE Limited gets NPCIL vendor approval for nuclear power supply chain6 Aug 2026Regulatory Product Approval+10.6% +20.3% +18.6%₹119618 Cr24.4vs 24.67.8%+27.5%
Steel City SecuritiesStockbroking & AlliedSteel City Securities gets Market Maker approval from NSE and BSE4 Aug 2026Regulatory Product Approval-2.5% -3.9% -2.1%₹79.81121 Cr7.0vs 15.813.8%+28.5%
Ashiana HousingResidential Commercial ProjectsJuly 2026 ops: Bookings at 501.76 Cr, OCs received for Gurugram projects1 Aug 2026Regulatory Product Approval-1.0% -3.8% -6.1%₹3703,719 Cr30.7vs 20.813.1%-63.3%
MAS Financial ServNon Banking Financial Company (NBFC)MAS Financial gets UIDAI approval for Aadhaar authentication services31 Jul 2026Regulatory Product Approval-2.6% -4.5% -8.2%₹2654,808 Cr12.2vs 18.9—+20.7%
Fischer Medical VentureMedical Equipment & SuppliesFischer Medical Ventures Gets CDSCO Import Approval for Spincare System30 Jul 2026Regulatory Product Approval+7.5% +9.6% -1.2%₹322,094 Cr13.3vs 21.911.3%+249.4%
Meghna Infracon InfraResidential, Commercial ProjectsMeghna Infracon delivers Riviera project in Goregaon in 16 months28 Jul 2026Regulatory Product Approval-0.4% -3.0% —₹6681,451 Cr214.1vs 18.433.9%+52.5%
Supreme Holdin N Hosp IResidential Commercial ProjectsCIDCO approves 3 extra floors at Belmac Infinity, project revised from G+10 to G+1327 Jul 2026Regulatory Product Approval+0.9% +2.0% -12.7%₹29.56114 Cr155.6vs 20.80.1%+1284.1%
Goodluck IndiaIron & Steel ProductsSubsidiary Gets Defence Quality Certification for Artillery Shells27 Jul 2026Regulatory Product Approval+0.2% +0.5% -70.6%₹4951,644 Cr7.9vs 17.013.5%+30.9%
Indo Tech TransformINDOTECHEnters 400 kV transformer segment with NTPC approval and initial order24 Jul 2026Regulatory Product Approval+1.9% +5.6% +9.4%₹3,1553,351 Cr33.732.4%+39.0%
Jeevan Scientific TechnologyHealthcare Research, Analytics & TechnologyUSFDA inspection closed with zero observations at Hyderabad facility24 Jul 2026Regulatory Product Approval+5.8% +8.0% +3.0%₹82.71165 Cr196.92.4%+111.6%
Kwality PharmaceuticalsPharmaceuticalsKwality Pharma gets CDSCO nod for Pembroluzimab preclinical batches24 Jul 2026Regulatory Product Approval+1.2% -3.0% +29.6%₹3,5163,648 Cr54.2vs 31.224.4%+35.8%
Bondada EngineeringTelecom - InfrastructureCEA approves 300 MW solar project energization at Khavda for NLC India23 Jul 2026Regulatory Product Approval-1.1% -2.7% -8.0%₹2843,168 Cr12.4vs 12.337.2%-36.6%
Telecanor GlobalSoftware ProductsPayment division update: PCI-DSS auditor appointed, RBI license pending21 Jul 2026Regulatory Product Approval+10.2% +11.1% -3.8%₹12.2919 Cr2.0vs 19.687.1%—
Sumit WoodsResidential Commercial ProjectsFull Commencement Certificate received for Borivali residential project21 Jul 2026Regulatory Product Approval+5.0% +3.9% +2.9%₹45.77219 Cr32.2vs 20.83.2%+6.9%
BTRFLY Gandhi ApplHousehold AppliancesIntimation of Award of Patent13 Jul 2026Regulatory Product Approval-2.0% -2.1% -14.1%₹545974 Cr20.3vs 41.616.2%+14.2%
RPG Life SciencesPharmaceuticalsRPG Life Sciences launches Naprosyn ES in India via Archerchem partnership13 Jul 2026Regulatory Product Approval-4.2% +4.3% -1.8%₹2,8304,679 Cr56.5vs 31.224.4%—
Page 2 of 2Previous
How this list is built

A company appears when an NSE/BSE filing inside the last 90 days carries one of these classifier signals (minimum importance: Medium): Regulatory Product Approval. Each row shows the latest qualifying filing; the reaction columns are the stock’s measured move 1 day, 1 week and 1 month after that filing.

MarketPing publishes facts, filings and measured history only — nothing on this page is investment advice, a recommendation or a rating.